Valuation : Haleon plc

Market Cap 32.88B 44.69B 38.36B 36B 62.06B 4,263B 62.36B 426B 165B 2,150B 168B 164B 7,123B P/E 2026 *
19.4x
P/E 2027 * 17.2x
Enterprise Value 39.76B 54.04B 46.38B 43.53B 75.03B 5,154B 75.4B 515B 200B 2,600B 203B 198B 8,612B EV / Sales 2026 *
3.49x
EV / Sales 2027 * 3.3x
Free-Float
98.46%
Yield 2026 *
2.16%
Yield 2027 * 2.4%
1 day-1.37%
1 week+2.85%
Current month+1.32%
1 month-0.57%
3 months+7.66%
6 months-6.62%
Current year-1.79%
1 week 355.8
Extreme 355.8
370.8
1 month 348.8
Extreme 348.8
384.2
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
2/12/26 Free

General Counsel

31 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.43%+2.85%+2.88%+12.71% 44.69B
-0.00%-4.63%+61.64%+114.24% 1,060B
-1.15%-0.22%+50.91%+62.39% 651B
-1.45%-0.97%+24.62%+75.87% 465B
-1.34%-2.18%+38.50%+40.34% 365B
-1.85%-1.14%+22.47%+38.07% 300B
-0.63%+0.93%+2.44%+12.57% 258B
+0.02%+1.63%+53.08%+71.82% 238B
-3.18%-0.37%-17.28%-54.36% 210B
+0.52%+3.67%+30.53%+93.02% 184B
Average -1.06%-0.17%+26.98%+46.67% 377.51B
Weighted average by Cap. -0.90%-2.08%+38.70%+66.14%

Financials

2026 *2027 *
Net sales 11.39B 15.48B 13.29B 12.47B 21.5B 1,477B 21.6B 148B 57.2B 745B 58.13B 56.87B 2,467B 11.87B 16.13B 13.85B 13B 22.4B 1,539B 22.51B 154B 59.61B 776B 60.58B 59.26B 2,571B
Net income 1.7B 2.31B 1.98B 1.86B 3.2B 220B 3.22B 21.99B 8.52B 111B 8.66B 8.47B 368B 1.92B 2.61B 2.24B 2.1B 3.62B 249B 3.64B 24.89B 9.64B 126B 9.8B 9.59B 416B
Net Debt 6.87B 9.34B 8.02B 7.53B 12.97B 891B 13.04B 89.07B 34.52B 450B 35.08B 34.32B 1,489B 6.26B 8.51B 7.31B 6.86B 11.82B 812B 11.88B 81.16B 31.45B 410B 31.96B 31.27B 1,357B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (31.4%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - pain relief medicines (23.2%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - respiratory medicines (17%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (15.3%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - medicines for digestive health (8.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - other (4.2%). Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.6%), North America (35.1%), and Asia/Pacific (23.3%).
Employees
24,535
Date Price Change Volume
26-08-27 GBX 367.90 -1.45% 9,578,399
26-08-26 GBX 373.30 +1.00% 18,446,563
26-08-25 GBX 369.60 -0.05% 20,004,843
26-08-24 GBX 369.80 +1.85% 19,864,563
26-08-21 GBX 363.10 +0.89% 14,337,114
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.733GBP
Average target price
4.214GBP
Spread / Average Target
+12.89%

Quarterly revenue - Rate of surprise